Status:

UNKNOWN

Serum Fetuin Level in Polycystic Ovary Syndrome

Lead Sponsor:

Aljazeera Hospital

Collaborating Sponsors:

Cairo University

National Research Centre, Egypt

Conditions:

Polycystic Ovary

Eligibility:

FEMALE

18-42 years

Brief Summary

polycystic ovary syndrome is a common gynecological problem

Detailed Description

Understanding the pathophysiology and the cause is of much importance for proper management of this problem

Eligibility Criteria

Inclusion

  • women who have PCOS in group 1 and who donnot have PCOS in group 2 with age between 20 -42 years

Exclusion

  • women above 42 years old

Key Trial Info

Start Date :

January 30 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 5 2020

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03819998

Start Date

January 30 2019

End Date

February 5 2020

Last Update

August 6 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Algazeerah and Kasralainy hospital

Giza, Egypt

Serum Fetuin Level in Polycystic Ovary Syndrome | DecenTrialz